Document Detail

miR-27b-regulated TCTP as a novel plasma biomarker for oral cancer: From quantitative proteomics to post-transcriptional study.
MedLine Citation:
PMID:  22902387     Owner:  NLM     Status:  Publisher    
We combined an iTRAQ-based quantitative proteomic analysis and the miRNA determination to profile potentially novel biomarker from oral cancer. There are 757 and 674 unique proteins identified from proteomic analysis, and 13 proteins displayed consistent underexpression (<0.67 fold) in normal tissues in comparison with the corresponding tumor tissues. After preliminary screening, EGFR, OAT, TPT1, ITGA6, G3BP1 and CB39L were the six genes validated in the 37 oral cancer patients (T1, n=10; T2, n=10; T3, n=10 and T4, n=7). The TPT1, ITGA6 and CAB39L genes were displayed the higher transcriptions level in the tumor tissues and the TPT1, ITGA6 and CAB39L proteins were also shown overexpression in the tumor tissues from the same patients. The miR-19a, 19b, 27a, 27b, 186, 203 and 377 transcripts were predicted and the miRNA-27a and 27b level was shown to significantly reduce in the tumor tissues and the plasma of OSCC patients. In the in vitro study, the overexpression of miR-27b only significantly decreased TCTP protein and gene levels in both HSC-3 and Cal-27 cell lines. Our results demonstrate that human miR-27b regulates the expression of the TCTP tumor protein, and circulating miR-27b may be useful as a biomarker for oral cancer research.
Wan-Yu Lo; Huang-Joe Wang; Chih-Wei Chiu; Sung-Fang Chen
Related Documents :
3116087 - Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes.
10376937 - Expression of granulocyte colony-stimulating factor in recurrent glial tumors is invers...
15501977 - Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-s...
10453037 - A novel function of il-12p40 as a chemotactic molecule for macrophages.
23255947 - Adenovirus-mediated combined anti-angiogenic and pro-apoptotic gene therapy enhances an...
21434797 - Targeting malignant b cells as antigen-presenting cells: tlr-9 agonist induces systemic...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-9
Journal Detail:
Title:  Journal of proteomics     Volume:  -     ISSN:  1876-7737     ISO Abbreviation:  J Proteomics     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101475056     Medline TA:  J Proteomics     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier B.V.
Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan; Division of Surgery, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan; Department of Life Science, National Chung Hsing University, Taichung, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Research monitoring by US medical institutions to protect human subjects: compliance or quality impr...
Next Document:  Comparison of commercial serum-free media for CHO-K1 cell growth and monoclonal antibody production.